“INNOVATION NUTRACEUTICAL AWARD 2025” for Microbiome Balance

 POSH Wins the “INNOVATION NUTRACEUTICAL AWARD 2025” for Microbiome Balance

 On September 19, 2025, at 2:00 PM, At Queen Sirikit National Convention Center, Bangkok.

 Posh Medica LifeTech Public Company Limited was proudly honored with the

“INNOVATION NUTRACEUTICAL AWARD 2025” in the category of Microbiome Balance

at the TRUSTED NUTRACEUTICAL PARTNER AWARDS 2025, organized by 3C GROUP during Food Ingredient Asia 2025 (FIA 2025).

 Ms. Lakkana Sermcharoenkit, Chief Innovation Officer (CIO), received the award on behalf of the company.

 This achievement reinforces POSH’s dedication to developing nutraceutical innovations that truly make a difference—using premium-quality extracts and advanced scientific research to promote Microbiome balance and sustainable health from within.

 “We are proud that POSH’s innovation has been recognized on such a significant stage. This award inspires us to keep creating high-quality supplements that improve people’s lives every day.”

 POSH extends heartfelt thanks to 3C GROUP for this valuable recognition and to all consumers for their trust.

We remain committed to advancing innovation and raising the standards of nutraceutical products for better health and a brighter future.